Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 4,081-4,092 of 4,306
Drug study icon
CompletedNCT04578756

Cariprazine for schizophrenia

This study is completed in the United States. It is testing cariprazine for schizophrenia.

Multiple locations, including Dothan
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDrugA study involving a medication or substance.From 5 Years to 17 Years
Countries
United States
Sponsor
AbbVie
Condition
Bipolarity, Schizophrenia
Drug study icon
TerminatedNCT01122927

Safety study of aripiprazole in schizophrenia

This study was terminated in the United States, in Bulgaria, in Croatia, .... It is testing aripiprazole for schizophrenia.

Multiple locations, including Dothan
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDrugFrom 10 Years to 17 Years
Countries
United States, Bulgaria, Croatia, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Bipolarity, Schizophrenia
Drug study icon
CompletedNCT00982020

Study in Adolescents With Schizophrenia or Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Lauderhill
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDrugFrom 13 Years to 17 Years
Countries
United States, Poland, Russia
Sponsor
Eli Lilly and Company
Condition
Bipolarity, Schizophrenia
Drug study icon
CompletedNCT03187769

Efficacy of ALKS 3831 on Body Weight for schizophrenia

This study is completed in the United States, in the United Kingdom, in Austria, .... It is testing Efficacy of ALKS 3831 on Body Weight for schizophrenia.

Multiple locations, including Little Rock
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDrugFrom 16 Years to 40 Years
Countries
United States, United Kingdom, Austria, ...
Sponsor
Alkermes, Inc.
Condition
Bipolarity, Schizophrenia
Drug study icon
CompletedNCT06041646

Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Little Rock
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
BioXcel Therapeutics Inc
Condition
Bipolarity, Schizophrenia
Drug study icon
CompletedNCT00044187

The Assessment of a Weight-Gain Agent for Olanzapine-Associated Anti-Obesity Agent in people with Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolarity type I

This study is completed in the United States. It focuses on schizophrenia.

Multiple locations, including El Centro
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Eli Lilly and Company
Condition
Bipolarity, Schizophrenia
Drug study icon
CompletedNCT03872596

study to Assess the Bioavailability of Quetiapine Versus Seroquel® in Subjects With Schizophrenia or Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Long Beach
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDrugFrom 18 Years to 45 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Bipolarity, Schizophrenia
Other study type icon
Not recruitingISRCTN28071919

Effectiveness of a case identification tool to increase helpseeking of people with probable mental health problems

This study is looking at whether Female community health volunteers (FCHVs) from 40 health facilities were randomly assigned (1:1) to: 1 can help people with Depression, psychosis, Addiction and epilepsy or Mental and Behavioural Disorders. Participants take part in Female community health volunteers (FCHVs) from 40 health facilities were randomly assigned (1:1) to: 1 and complete follow-up assessments.

In Nepal
Why is this study shown?

This study includes Schizophrenia among several conditions.

Addiction, Schizophrenia, ...Other
Countries
Nepal
Sponsor
TPO Nepal
Condition
Addiction, Schizophrenia, ...
Drug study icon
CompletedNCT00454883

Non-interventional Study of Ziprasidone in the Treatment of Bipolar and Schizoaffective Disorders.

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, Schizophrenia, ...DrugOver 18 Years
Countries
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity, Schizophrenia, ...
Behavioral study icon
CompletedNCT02276469

Peer Support for Severe Mental Disorders

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, Schizophrenia, ...BehavioralOver 17 Years
Countries
Sponsor
Universitätsklinikum Hamburg-Eppendorf
Condition
Bipolarity, Schizophrenia, ...
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.